DNA Vaccine Market is Poised for an Impressive Growth!

2026-07-06 09:49:45 Health and Fitness

596

According to a new research report by RNCOS entitled, ?Global DNA Vaccine Market Outlook 2020?, Nucleic acid vaccines have the potential to change the vaccination landscape through easier, more scalable, less expensive and logistically simpler vaccines that are more efficient in preventing infectious disease. As compared to other types of vaccines (e.g., live attenuated or killed whole organism vaccines, and subunit vaccine), DNA vaccines are safe, easy to prepare and store, and cost effective. In addition, DNA vaccines allow for focused immunity on the antigen of interest and have the ability to induce natural, long-lasting, and varied immune responses in vivo. With the advent of biotechnology in the vaccine manufacturing process, there will be a tremendous growth in DNA vaccine development. The global market share of these products is likely to get double in the next few years. Several pharmaceutical majors such as Merck, Pfizer, Sanofi, GSK etc. are managing robust pipeline of DNA Vaccines owing to which market is expected to be flooded with next generation therapies in coming years.

According to RNCOS, the industry is expected to grow at a CAGR of 30% during 2014-2020. Rising incidences of chronic diseases, increasing investments in R&D, and weakness of live attenuated vaccines in treating several diseases such as melanoma as well as HIV are some of the influencing factors supporting the grow of DNA Vaccines. The pharmaceutical industry is showing immense interest in DNA and RNA nucleic acid vaccines through strategic alliances, positive clinical trial results and development in Vaccine delivery technologies.

Research Analysis and Highlights

The report is spreaded across 50 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Global DNA Vaccine industry. The report provides a clear picture of the factors driving the industry growth, and challenges faced by the industry. In addition to this, the study includes industry developments that have occurred during past three years. The report further highlights market segmentation of the industry by types of clinical segment, therapeutic targets. Separate section is allotted to recommendations to boost the global industry. With special emphasis on competitive landscape and dominant players in the market, the research provides valuable information to the investors who are looking to enter in this market.

Some of the key highlights of the report include the following:

? Advancements in Delivery Systems Aiding Growth
? Expanding applications Increasing Popularity of DNA Vaccines
? Pfizer Leads the Human DNA Vaccine Market
? Infectious Disease Remained the largest attraction for DNA Vaccines

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM813%20.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.